Skip to content

The Potential Association of Long Non-coding RNA (NEAT1 and MALAT1) in the Process of Epithelial-mesenchymal Transition in Periodontitis

The Potential Association of Long Non-coding RNA (NEAT1 and MALAT1) in the Process of Epithelial-mesenchymal Transition in Periodontitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05995067
Enrollment
48
Registered
2023-08-16
Start date
2022-02-14
Completion date
2024-01-30
Last updated
2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epithelial Mesenchymal Transition, Long Noncoding RNA, Periodontal Disease, AVDC Stage 3and 4

Brief summary

Periodontitis is a polymicrobial, inflammatory condition affecting tooth-supporting tissues. It is characterized by a progressive loss of epithelial attachment and resorption of alveolar bone, which can lead to tooth loss. Epithelial-mesenchymal transition (EMT) has been proposed as a reversible process that shifts the cell phenotype from epithelial to mesenchymal-like and may be involved in the process of periodontal inflammation either completely or partially. Long non-coding RNAs (lncRNAs) are a large class of regulatory transcripts longer than 200 nucleotides lacking evident protein-coding potential. Studies have shown that lncRNA dysregulation plays key roles in human diseases, including cancer, by modulating the epithelial-mesenchymal transition (EMT). The involvement of lncRNAs markers in the pathogenesis of periodontal disease induced EMT has not been studied thoroughly and have created a gap in the knowledge.

Interventions

OTHERperiodontitis challenge

control will be compared to diseased group suffering from periodontal disease.

Sponsors

Ali A Abdulkareem
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients with no history of systemic disease e.g., diabetes. * Both males and females will be included in the study. * Control group: patients fit the case definition of gingival health2, and confirmed by Histopathological inflammatory cell infiltration analysis. * Periodontitis group: patients fit the case definition of periodontal disease referred for periodontal flap surgery (modified Widman's flap). * Patients radiographically confirmed with infrabony pocket eligible for periodontal flap surgery.

Exclusion criteria

* Patients not willing to participate or consent. * Patient taking medications that affect or modify immunity (e.g., corticosteroid), for the last 3 months. * Patient taking NSAIDs for the last 3 months. * Active smoker.

Design outcomes

Primary

MeasureTime frameDescription
determining the relative expression of lncRNAs (NEAT1 and MALAT1) in healthy and diseased periodontal tissue.one yearreverse transcription real time polymerase chain reaction

Secondary

MeasureTime frameDescription
determine the expression of EMT-related genes (E-cadherin, Vimentin, β-catenin, and Snail1), in healthy and diseased tissues, and their correlation with lncRNAs and clinical parameters.one yearreverse transcription real time polymerase chain reaction

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026